Australian Consumer Services Stock News

Artificial intelligence is shaping everything from semiconductors and cloud infrastructure to everyday software tools, even as global growth signals remain mixed and inflation trends vary by region. While some economies show steady services activity and others face softer demand, companies tied directly to the ChatGPT and AI build out remain at the center of long term digital transformation. This AI Stocks screener focuses on businesses involved in chips, large language models, cloud and...

Orica (ASX:ORI) has confirmed it will proceed with a commercial scale green hydrogen facility in the Hunter Valley, aiming to cut emissions by partially replacing natural gas feedstock within its existing operations. See our latest analysis for Orica. Orica's green hydrogen decision comes after a period where short term share price momentum has picked up, with a 90 day share price return of 18.56%, while the 1 year and 5 year total shareholder returns of 25.56% and 105.89% point to stronger...

Why JB Hi-Fi is back in focus for dividend investors JB Hi-Fi (ASX:JBH) is back on investors’ radar after recent coverage highlighted its dividend appeal alongside resilient sales, even as rising supplier costs and stronger competition keep retail sector margins under scrutiny. This renewed attention comes as income-focused investors weigh JB Hi-Fi’s cash flow profile and dividend record in the context of questions about discretionary spending, household budgets and the extent to which...

Champion Iron (ASX:CIA) is drawing fresh attention after announcing the first production of direct reduction (DR) quality iron ore at its Bloom Lake DRPF Project, alongside preparations for an inaugural large-scale commercial shipment. See our latest analysis for Champion Iron. These DR production milestones come after a period where Champion Iron's share price has fallen 24.1% over 90 days and 34.1% year to date, while the 1 year total shareholder return is down 7.3%. This suggests that...

In late June 2026, Mesoblast received a Biologics License Application filing number from the U.S. FDA and requested modular review for rexlemestrocel-L to prevent life-threatening gastrointestinal bleeding in end-stage heart failure patients supported by left ventricular assist devices, building on its Orphan Drug and RMAT designations. The filing comes as new FDA draft guidance reiterates a flexible approach to therapies for rare, high-mortality conditions, potentially aligning closely with...

PEXA Group recently announced a leadership reshuffle in its UK business, appointing Krystle Kocik and Simon Wright as Co-CEOs, alongside adding two independent non-executive directors, Janelle Hopkins and John Hooper, to its board. These leadership and governance changes, combined with PEXA’s engagement on IPART’s draft review of ELNO service fees, could reshape how investors assess its UK expansion and regulatory risk profile. We’ll now examine how the new Co-CEO structure in PEXA UK may...

Arafura Rare Earths (ASX:ARU) has attracted fresh attention after signing a binding term sheet to supply neodymium praseodymium oxide, and is moving toward final funding approvals and imminent construction at its Nolans Project. See our latest analysis for Arafura Rare Earths. At a share price of A$0.25, Arafura Rare Earths has seen a 7 day share price return of 6.38%, while the 30 day and 90 day share price returns are down 10.71% and 16.67% respectively. Over a longer period, the 1 year...

Xero Limited recently launched Industry Benchmarks in Xero Analytics and rolled out a Microsoft 365 integration that brings real-time Xero financial data and its JAX AI assistant into Microsoft 365 Copilot and core Office apps. Together, these moves deepen Xero’s AI capabilities and embed its platform inside widely used productivity tools, potentially changing how small businesses and advisors run and interpret their finances day to day. Next, we’ll examine how this deeper Microsoft 365...

Founder-led stocks can offer something many investors look for, especially when global data feels mixed on growth, inflation, and policy direction. With services sectors holding up in several regions, inflation showing pockets of relief, and energy and geopolitical risks still in focus, commitment at the top of a company can matter even more. The Top Founder-Led Companies screener focuses on leaders with meaningful skin in the game and strong capital efficiency, so you are not just backing a...

AI is no longer just a big tech story. While global data points show mixed growth, cooling inflation in some regions and a steady recovery in services and manufacturing, smaller AI-focused companies are quietly building tools in machine learning, automation, and data intelligence that aim to solve very specific problems. That is where the AI Small Caps screener comes in. It helps you filter for early-stage opportunities that might otherwise be buried under the headlines about mega caps. In...

Elevra Lithium has completed the groundbreaking of its North American Lithium Expansion project, following a May 2026 capital raise that fully funded Stage 1 and allowed equipment orders to support its planned development timeline. By targeting a 15–20% uplift in spodumene concentrate capacity and lower unit operating costs, the expansion underlines Elevra Lithium’s push to supply more traceable lithium to electric vehicle and energy storage customers. Next, we’ll examine how fully funded...

Gold mining stocks are back in focus after a key shift in the macro backdrop. Softer U.S. jobs data, reduced expectations for further Federal Reserve rate hikes and renewed central bank demand for bullion have all supported gold prices, giving fresh attention to companies that pull the metal out of the ground. For investors, that combination can change how risk and reward stack up across gold mining stocks screened for financial strength and specific country exposure. This article looks at 3...

In a world where inflation signals, interest rate expectations and growth data keep shifting, many investors are looking for income that feels more reliable than the latest macro headline. That is where Dividend Powerhouses with yields above 5% and well covered, growing payouts can help. This screener focuses on companies that have kept dividends both stable and on an upward path, which can be appealing when bond yields, labor data and central bank messages keep moving around. In this...

Penny stocks often sound like pure speculation, but the Financially Fit Penny Stocks screener takes a very different approach. With inflation, interest rate decisions and mixed economic data moving markets, many investors are looking for smaller companies with healthier balance sheets instead of chasing every headline. This screener focuses on penny stocks trading below $5 that also show solid financial health, which can help you focus on businesses with a lower risk profile than many early...

In recent weeks, Evolution Mining has been in focus as gold prices rebounded on a softer US dollar and easing interest-rate expectations, lifting investor attention on the company’s gold and copper exposure. At the same time, investors are increasingly weighing Evolution’s operational quality, cost control and balance sheet strength rather than relying solely on broad gold sector momentum. We’ll now examine how this renewed focus on operational quality amid improving gold prices may...

As the Australian market opens the new financial year flat, with the ASX hovering around 8,780 points, global markets are showing mixed signals amid ongoing geopolitical tensions and tech-driven rallies. In such a landscape, identifying promising investment opportunities requires a keen eye for stocks that balance affordability with potential for growth. Penny stocks, often representing smaller or newer companies, continue to capture investor interest due to their unique blend of...

In the past few days, Cochlear Limited cut its FY26 underlying net profit guidance to A$290 million–A$330 million, citing weaker implant demand in developed markets, Middle East delivery and receivables risk, margin pressure, and higher restructuring costs. This guidance downgrade highlights how operational challenges in key geographies and rising costs can alter expectations for a business often viewed as a core ASX healthcare exposure. We’ll now examine how Cochlear’s reduced FY26 profit...

Telix Pharmaceuticals (ASX:TLX) is back in focus after a Type B meeting with the U.S. Food and Drug Administration confirmed that safety data from its ProstACT Global Phase 3 trial supports moving TLX591-Tx into Part 2. See our latest analysis for Telix Pharmaceuticals. Alongside the FDA update, Telix Pharmaceuticals has drawn fresh attention after a strong 30-day share price return of 36.03% and year to date share price return of 51.23%. However, the 1-year total shareholder return declined...

With inflation signals mixed and central banks keeping options open on interest rates, many investors are looking for assets tied to real world energy demand rather than just policy swings. Nuclear energy stocks sit squarely in that camp, linking company fortunes to long term power needs, supply chains and geopolitical decisions around fuel security. The Nuclear Energy Stocks screener is designed to help you focus on listed businesses across uranium production, enrichment and reactor...

The recent move in nickel and cobalt prices, together with investor caution around funding large battery metals projects, has put Sunrise Energy Metals (ASX:SRL) back in focus for sector risk and valuation. See our latest analysis for Sunrise Energy Metals. Despite recent sector-wide pressure that saw Sunrise Energy Metals sold off alongside other battery-metal stocks, the current A$16.99 share price sits against a 30 day share price return of 13.27% and a very large 1 year total shareholder...

With inflation trends mixed across regions, interest rates in focus and labour markets still holding up, many investors are looking for stocks that can grow earnings even as conditions shift. That is where the Healthy high growth potential screener comes in. It filters for companies that analysts expect to grow earnings strongly over the next 3 years while also passing basic financial health checks. In this article, you will see 3 stocks from this screener, along with a clear, plain-English...

Boss Energy (ASX:BOE) is back in focus after restarting uranium production at its Honeymoon project and receiving an analyst upgrade, drawing fresh attention to the stock despite ongoing ramp up and pricing challenges. See our latest analysis for Boss Energy. Boss Energy's A$1.19 share price has rebounded in the very short term, with a 1 day share price return of 3.03% and 7 day share price return of 12.26%. This sits against a 90 day share price return down 24.44% and a 1 year total...

Some of the losses seen by insiders who purchased AU$222.2k worth of Kuniko Limited ( ASX:KNI ) shares over the past...

Elliott Investment Management has put Northern Star Resources (ASX:NST) in focus after calling for substantial board changes and a comprehensive review of the business, following recent leadership changes at the gold producer. See our latest analysis for Northern Star Resources. Northern Star Resources shares closed at A$19.83 after a 1 day share price gain of 5.48%. The 30 day and year to date share price returns are still down, while the 5 year total shareholder return of 122.20% points to...